About U.O.C. Ematologia - Ospedale S.Eugenio
L'ospedale Sant'Eugenio si trova a Roma nel territorio del IX municipio.
Clinical Trials at U.O.C. Ematologia - Ospedale S.Eugenio
During the past decade, U.O.C. Ematologia - Ospedale S.Eugenio conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 2 clinical trials were completed, i.e. on
average, 13.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "U.O.C. Ematologia - Ospedale S.Eugenio" #1 sponsor was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 28 trials, followed by "Fondazione Italiana Linfomi ONLUS" with 3 trials
sponsored, "European Myeloma Network" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "U.O.C. Ematologia - Ospedale S.Eugenio"
#1 collaborator was "CML Advocates Network" with 1 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator, "European Leukemia Net" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "Fondazione EMN Italy Onlus" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at U.O.C. Ematologia - Ospedale S.Eugenio
According to Clinical.Site data, the most researched conditions in "U.O.C. Ematologia - Ospedale S.Eugenio" are
"Chronic Myeloid Leukemia" (7 trials), "Acute Lymphoblastic Leukemia" (2 trials), "Acute Myeloid Leukemia" (2 trials), "Adult" (2 trials) and "BCR-ABL Positive" (2 trials). Many other conditions were trialed in "U.O.C. Ematologia - Ospedale S.Eugenio" in a lesser frequency.
Clinical Trials Intervention Types at U.O.C. Ematologia - Ospedale S.Eugenio
Most popular intervention types in "U.O.C. Ematologia - Ospedale S.Eugenio" are "Drug" (20 trials), "Other" (8 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.
The name of intervention was led by "Imatinib" (3 trials), "Nilotinib" (3 trials), "Cyclophosphamide" (2 trials), "Ponatinib" (2 trials) and "ABVD" (1 trials). Other intervention names were less common.
Clinical Trials Genders at U.O.C. Ematologia - Ospedale S.Eugenio
The vast majority of trials in "U.O.C. Ematologia - Ospedale S.Eugenio" are
34 trials for "All" genders.
Clinical Trials Status at U.O.C. Ematologia - Ospedale S.Eugenio
Currently, there are NaN active trials in "U.O.C. Ematologia - Ospedale S.Eugenio".
undefined are not yet recruiting,
3 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 16 completed trials in U.O.C. Ematologia - Ospedale S.Eugenio,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in U.O.C. Ematologia - Ospedale S.Eugenio, 1 "Phase 1"
clinical trials were conducted, 11 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".